The thyrotropin receptor, a GPCR with a built-in inverse agonist

International Congress Series

Volumn 1249, Issue C, 2003, Pages 217-223

  Vassart, Gilbert ^a   Costagliola, Sabine ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

7TM receptors; Constitutive activation; Glycoprotein hormone receptors; GPCR; Inverse agonist

Indexed keywords

EID: 67349283391     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0531-5131(03)00603-4     Document Type: Article

References (30)

1. Dias, J.A., Van Roey, P., Structural biology of human follitropin and its receptor. Arch. Med. Res. 32 (2001), 510–519.
2. Lapthorn, A.J., Harris, D.C., Littlejohn, A., et al. Crystal structure of human chorionic gonadotropin. Nature 369 (1994), 455–461.
3. Segaloff, D.L., Ascoli, M., The lutropin/choriogonadotropin receptor… 4 years later. Endocr. Rev. 14 (1993), 324–347.
4. Vassart, G., Dumont, J.E., The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocr. Rev. 13 (1992), 596–611.
5. Vassart, G., Parma, J., Van Sande, J., Dumont, J., The thyrotropin receptor and the regulation of thyrocyte function and growth: update 1994. Endocr. Rev. 3 (1994), 77–80.
6. Rapoport, B., Chazenbalk, G.D., Jaume, J.C., McLachlan, S.M., The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr. Rev. 19 (1998), 673–716 (In Process Citation).
7. Kobe, B., Deisenhofer, J., A structural basis of the interactions between leucine-rich repeats and protein ligands. Nature 374 (1995), 183–186.
8. Kobe, B., Deisenhofer, J., Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats. Nature 366 (1993), 751–756.
9. Kajava, A.V., Vassart, G., Wodak, S.J., Modeling of the three-dimensional structure of proteins with the typical leucine-rich repeats. Structure 3 (1995), 867–877.
10. Bhowmick, N., Huang, J., Puett, D., Isaacs, N.W., Lapthorn, A.J., Determination of residues important in hormone binding to the extracellular domain of the luteinizing hormone/chorionic gonadotropin receptor by site-directed mutagenesis and modeling. Mol. Endocrinol. 10 (1996), 1147–1159.
11. Costagliola, S., Panneels, V., Bonomi, M., et al. Tyrosine sulfation is required for agonist recognition by glycoprotein hormone receptors. EMBO J. 21 (2002), 504–513.
12. Parma, J., Duprez, L., Van Sande, J., et al. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365 (1993), 649–651.
13. Kosugi, S., Okajima, F., Ban, T., Hidaka, A., Shenker, A., Kohn, L., Mutation of alanine 623 in the third cytoplasmic loop of the rat TSH receptor results in a loss in the phosphoinositide but not cAMP signal induced by TSH and receptor autoantibodies. J. Biol. Chem. 267 (1992), 24153–24156.
14. Refetoff, S., Dumont, J.E., Vassart, G., Thyroid Disorders. Scriver, C.R., (eds.) The Metabolic and Molecular Bases of Inherited Diseases, 8th ed., 2001, McGraw-Hill, New York, 4029–4076.
15. Themmen, A.P.N., Huhtaniemi, I.T., Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr. Rev. 21 (2000), 551–583.
16. Kudo, M., Osuga, Y., Kobilka, B.K., Hsueh, A.J., Transmembrane regions V and VI of the human luteinizing hormone receptor are required for constitutive activation by a mutation in the third intracellular loop. J. Biol. Chem. 271 (1996), 22470–22478.
17. Claeysen, S., Govaerts, C., Lefort, A., et al. A conserved Asn in TM7 of the TSH receptor is a common requirement for activation by both mutations and its natural agonist. FEBS Lett. 517 (2002), 195–200.
18. Govaerts, C., Lefort, A., Costagliola, S., et al. A conserved ASN in TM7 is a on/off switch in the activation of the TSH receptor. J. Biol. Chem., 2001.
19. Tiosano, D., Pannain, S., Vassart, G., et al. The hypothyroidism in an inbred kindred with congenital thyroid hormone and glucocorticoid deficiency is due to a mutation producing a truncated thyrotropin receptor. Thyroid 9 (1999), 887–894.
20. Parma, J., Duprez, L., Van Sande, J., Hermans, J., Van Vliet, G., Costagliola, S., Rodien, P., Dumont, J.E., Vassart, G., Diversity and prevalence of somatic mutations in the TSH receptor and Gs alpha genes as a cause of toxic thyroid adenomas. J. Clin. Endocrinol. Metab. 82 (1997), 2695–2701.
21. Van Sande, J., Massart, C., Costagliola, S., et al. Specific activation of the thyrotropin receptor by trypsin. Mol. Cell. Endocrinol. 119 (1996), 161–168.
22. Vlaeminck, V., Ho, S.C., Rodien, P., Vassart, G., Costagliola, S., Activation of the cAMP pathway by the TSH receptor involves switching of the ectodomain from a tethered inverse agonist to an agonist. Mol. Endocrinol. 16 (2002), 736–746.
23. Zhang, M., Tong, K.P., Fremont, V., et al. The extracellular domain suppresses constitutive activity of the transmembrane domain of the human TSH receptor: implications for hormone–receptor interaction and antagonist design. Endocrinology 141 (2000), 3514–3517.
24. Gether, U., Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr. Rev. 21 (2000), 90–113.
25. Samama, P., Cotecchia, S., Costa, T., Lefkowitz, R.J., A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. J. Biol. Chem. 268 (1993), 4625–4636.
26. Ji, I., Ji, T., Human choriogonadotrophin binds to a lutropin receptor with essentially no N-terminal extension and stimulates cAMP synthesis. J. Biol. Chem. 266 (1991), 1306–1309.
27. Nishi, S., Nakabayashi, K., Kobilka, B., Hsueh, A.J., The ectodomain of the luteinizing hormone receptor interacts with exoloop 2 to constraint the transmembrane region: studies using chimeric human and fly receptors. J. Biol. Chem. 277 (2002), 3958–3964.
28. Duprez, L., Parma, J., Costagliola, S., et al. Constitutive activation of the TSH receptor by spontaneous mutations affecting the N-terminal extracellular domain. FEBS Lett. 409 (1997), 469–474.
29. Nakabayashi, K., Kudo, M., Kobilka, B., Hsueh, A.J., Activation of the luteinizing hormone receptor following substitution of Ser-277 with selective hydrophobic residues in the ectodomain hinge region. J. Biol. Chem. 275 (2000), 30264–30271.
30. Ho, S.C., Van Sande, J., Lefort, A., Vassart, G., Costagliola, S., Effects of mutations involving the highly conserved S281HCC motif in the extracellular domain of the thyrotropin (TSH) receptor on TSH binding and constitutive activity. Endocrinology 142 (2001), 2760–2767.